Beyaz

Drug Overview

Beyaz is a sophisticated, multi-functional medication within the Gynecology drug category. It is classified as a Combined Oral Contraceptive (COC), but it serves as much more than a method of family planning. It represents a unique approach to women’s health by combining hormonal regulation with nutritional support.

As a potent Hormone Modulator, Beyaz is formulated to address a spectrum of concerns that many women face throughout their reproductive years. Beyond its primary role in birth control, it is specifically designed to manage the physical and emotional symptoms of premenstrual dysphoric disorder (PMDD) and treat moderate acne. A distinctive feature of Beyaz is the inclusion of levomefolate calcium, a form of Vitamin B9 (folic acid), which supports long-term wellness.

• Generic Name: Drospirenone, Ethinyl Estradiol, and Levomefolate Calcium
• US Brand Names: Beyaz
• Route of Administration: Oral (Tablet)
• FDA Approval Status: Fully FDA-approved for pregnancy prevention, treatment of PMDD symptoms, management of moderate acne vulgaris, and supplementation of folate levels.

What Is It and How Does It Work? (Mechanism of Action)

Beyaz functions as a systemic Hormone Modulator and Targeted Therapy by interacting with the body’s endocrine and metabolic pathways. Its effectiveness is rooted in its ability to influence the hypothalamic-pituitary-ovarian (HPO) axis, which is the “control center” for the female reproductive cycle.

Hormonal Regulation

The medication contains two primary hormones: Ethinyl Estradiol (a synthetic estrogen) and Drospirenone (a unique progestin). Under natural conditions, the hypothalamus releases pulses of Gonadotropin-Releasing Hormone (GnRH), which triggers the pituitary gland to produce Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). These hormones signal the ovaries to mature and release an egg.

Beyaz provides continuous negative feedback to this system. By maintaining steady levels of estrogen and progestin, it “tricks” the brain into believing ovulation has already occurred. This prevents the mid-cycle surge of LH, ensuring that the ovaries remain in a dormant state and no egg is released.

Molecular Specificity of Drospirenone

Unlike older progestins, Drospirenone is a molecular analog of the medication spironolactone. At the molecular level, it acts as a receptor antagonist for aldosterone and androgens:

1. Anti-mineralocorticoid Activity: It blocks aldosterone receptors, which helps the body resist sodium and water retention. This is why many women experience less bloating and weight gain on Beyaz compared to other pills.
2. Anti-androgenic Activity: It blocks androgen receptors, which lowers the activity of male-type hormones in the skin. This directly reduces the production of sebum (oil) in the pores, effectively treating acne.

Nutritional Integration

The inclusion of Levomefolate Calcium (0.451 mg) is a strategic intervention. Folate is essential for DNA synthesis and repair. By providing a stable daily dose, Beyaz ensures that women maintain high folate levels. This is a critical preventive measure for neural tube defects in the event of a future pregnancy, providing a safety net for women of reproductive potential.

FDA-Approved Clinical Indications

Beyaz is one of the few contraceptives with a broad range of FDA-approved uses, making it a versatile tool for comprehensive patient care.

Primary Gynecological/Obstetric Indications

• Pregnancy Prevention: High-efficacy contraception for women choosing an oral regimen.
• Premenstrual Dysphoric Disorder (PMDD): For women who experience severe physical and emotional symptoms (such as extreme irritability, anxiety, or depression) that interfere with daily life.
• Acne Vulgaris Treatment: Specifically for the treatment of moderate acne in women at least 14 years of age who desire contraception.
• Folate Supplementation: To increase folate levels in women of reproductive age to reduce the risk of neural tube defects.

Off-Label / Endocrinological Indications

• Polycystic Ovary Syndrome (PCOS): Utilized to regulate irregular menstrual cycles and reduce hirsutism (excess hair growth) due to the anti-androgenic properties of drospirenone.
• Endometriosis Symptom Management: Used to suppress the cyclical hormonal shifts that cause pain and tissue growth in endometriosis patients.
• Cycle Regulation: Establishing a predictable bleeding pattern for women with irregular or heavy periods.

Dosage and Administration Protocols

Beyaz is administered in a 28-day cycle. It follows a “24/4” regimen, meaning there are 24 days of active hormone tablets followed by 4 days of tablets containing only folate. This shorter “hormone-free” interval helps stabilize mood and physical symptoms.

Dose Adjustments and Special Populations:

• Renal/Hepatic Insufficiency: Beyaz is contraindicated in patients with renal impairment or hepatic disease. Drospirenone can increase potassium levels, which is dangerous if kidney or liver function is compromised.
• Adrenal Insufficiency: Contraindicated due to the risk of hyperkalemia.
• Missed Doses: If one active pill is missed, take it as soon as remembered. If two are missed, take two for two days and use backup contraception (condoms) for seven days.

Clinical Efficacy and Research Results

Clinical study data from 2020–2026 reinforce that Beyaz remains a gold standard for multi-symptom management.

• Contraceptive Efficacy: The Pearl Index for this formulation is approximately 0.1 with “Perfect Use,” meaning fewer than one pregnancy occurs per 100 women per year. Under “Typical Use,” the failure rate is approximately 7% to 9%.
• PMDD Resolution: In randomized, double-blind, placebo-controlled trials, women taking the drospirenone/ethinyl estradiol combination showed a significant reduction in their Daily Record of Severity of Problems (DRSP) scores. Research indicates a 48% to 60% improvement in emotional and physical symptom clusters compared to placebo.
• Acne Improvement: In clinical trials, users experienced a statistically significant reduction in inflammatory and non-inflammatory lesion counts. Precise numerical data show a mean reduction of 42% to 46% in total acne lesions over six months of therapy.
• Folate Levels: Studies confirm that daily levomefolate calcium maintains blood folate levels above the threshold (906 nmol/L) required to significantly reduce the risk of neural tube defects.

Safety Profile and Side Effects

BLACK BOX WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular side effects from combined oral contraceptive use. This risk increases with age, particularly in women over 35 years, and with the number of cigarettes smoked. Women who use Beyaz are strongly advised not to smoke.

Common Side Effects (>10%)

• Headache: Often mild and typically occurs during the transition between active and inert tablets.
• Nausea and Breast Tenderness: Common during the first 2–3 months as the body adjusts to the Hormone Modulator.
• Menstrual Irregularities: Spotting or breakthrough bleeding during the first few cycles.
• Mood Changes: While it treats PMDD, some women may experience general mood fluctuations.

Serious Adverse Events

• Hyperkalemia (High Potassium): Because drospirenone is an anti-mineralocorticoid, it can cause the body to retain potassium. This is a unique risk not found in older birth control pills.
• Venous Thromboembolism (VTE): An increased risk of blood clots in the legs or lungs. Some studies suggest drospirenone-containing pills have a slightly higher VTE risk than those containing levonorgestrel.
• Hypertension: New onset or worsening of high blood pressure.

Management Strategies:

Patients should be screened for high potassium before starting and should avoid potassium-sparing diuretics or excessive NSAID use. To manage nausea, take the pill at bedtime or with a meal. If “ACHES” symptoms occur (Abdominal pain, Chest pain, Headaches, Eye problems, or Severe leg pain), seek emergency medical help immediately.

Research Areas

Beyaz remains central in gynecological research. Current trials (2025–2026) explore how COCs modulate the vaginal microbiome, supporting protective Lactobacilli and reducing bacterial vaginosis recurrence. In regenerative medicine, levomefolate-containing contraceptives are studied for “folate-priming” to optimize endometrial conditions before stem-cell therapies. Research also investigates long-acting vaginal rings for targeted delivery, improving adherence, and reducing systemic effects.

Disclaimer: Studies regarding the use of bioidentical hormones for neuroprotective or vasculoprotective roles, and the development of “precision hormone therapy” models where hormone ratios are adjusted based on individual pharmacogenomic metabolic markers, are currently in the research phase and are not yet applicable to practical or professional clinical scenarios.

Patient Management and Practical Recommendations

Effective management requires a thorough baseline assessment and ongoing vigilance.

Pre-treatment Tests

• Potassium Levels: Specifically for women taking other medications that increase potassium (e.g., ACE inhibitors).
• Blood Pressure Screening: Mandatory before initiation.
• Pregnancy Test: To rule out an existing pregnancy.
• Liver and Kidney Function Tests: To ensure safe metabolism of drospirenone.

Precautions During Treatment

• Symptom Vigilance: Report any calf pain, shortness of breath, or sudden vision changes.
• Lifestyle Adjustments: Smoking cessation is critical. Patients should also maintain moderate potassium intake (avoiding “low-sodium” salt substitutes containing potassium chloride).
• Medication Review: Inform all healthcare providers that you are taking a drospirenone-containing pill to avoid drug-drug interactions.

“Do’s and Don’ts”

• DO take the pill at the same time every single day to maintain its effectiveness against PMDD and acne.
• DO use a backup contraceptive (condoms) for the first seven days of your first pack.
• DO stay hydrated to support the anti-mineralocorticoid effects of the medication.
• DON’T smoke while taking Beyaz, especially if you are over 35.
• DON’T stop the medication because of mild spotting; it often resolves within 2–3 months.
• DON’T skip the orange tablets; the folate is essential for your long-term health.

Legal Disclaimer

This guide is provided for informational purposes only and does not replace the professional medical advice, diagnosis, or treatment provided by a qualified healthcare professional. Always seek the advice of your physician, gynecologist, or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this guide. Beyaz is a prescription medication and should only be used under the direct supervision of a licensed physician.